Propét USA has been acquired by Merit Capital Partners and Aiglon Capital
The shareholders of Propét USA, Inc. have sold the company to Merit Capital Partners and Aiglon Capital.
Propét is a leading supplier of comfort footwear products across an extensive range of sizes and widths, selling through various major retailers, online marketplaces and medical establishments with powerful dropship capabilities. The company is driven by a mission to offer quality footwear for hard-to-fit feet with over 500 styles to support a wide range of activities. Founded in 1985, Propét has a rich heritage in designing, developing, and selling quality shoes for anyone seeking healthier and more dependable footwear.
Merit Capital Partners is a private investment firm which invests both equity and subordinated debt in each transaction. It partners with business owners, management teams and independent sponsors to provide flexible capital for management buyouts, recapitalizations, acquisition financings and other shareholder liquidity events.
Aiglon Capital is a private investment firm that acquires, manages, and grows middle-market manufacturing, distribution, and services companies.
Oaklins’ team in Los Angeles acted as the exclusive advisor to the seller in this transaction.
Contáctese con el equipo de la transacción
James Freedman
Oaklins Intrepid
Brian Levin
Oaklins Intrepid
Transacciones relacionadas
Den Berk Délice accelerates growth through strategic partnership
Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.
Conozca másXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Conozca másMicrofinanciera Fundeser has been sold to Grupo Financiero Atlántida
Incofin has successfully exited its investment in Microfinanciera Fundeser in Nicaragua through two of its funds: Rural Impulse Fund II (RIF II) and agRIF. It has sold 100% of its stake in Microfinanciera Fundeser to Grupo Financiero Atlántida through its subsidiary, Inversiones Tres Lagos.
Conozca más